论文部分内容阅读
目的分析顽固性上腹部癌痛患者经连续膈肌脚后间隙阻滞治疗的临床效果。方法本研究对象选取2013年8月至2015年2月64例顽固性上腹部癌痛患者,根据随机数字表法分成A组和B组。其中A组患者采取的治疗方式为单次腹腔神经丛阻滞,B组患者采取的治疗方式为连续膈肌脚后间隙阻滞。对比两组患者治疗1个月、6个月时的优良率,并对比治疗前、治疗1个月和6个月时的疼痛分数、生存质量。结果经过数据统计发现,两组治疗1个月时优良率相似,两组治疗前和治疗1个月时疼痛分数、生存质量相似,组间无显著统计学差异(P>0.05)。治疗6个月时,B组患者优良率明显高于A组患者,疼痛分数、生存质量明显优于A组患者,组间有显著的统计学差异(P<0.05)。结论顽固性上腹部癌痛患者经连续膈肌脚后间隙阻滞治疗的临床效果确切,可减轻患者疼痛,提升其生活质量,值得推广。
Objective To analyze the clinical effect of refractory upper abdominal cancer pain patients treated with continuous diaphragmatic muscle space block. Methods Sixty-four patients with refractory upper abdominal cancer pain were selected from August 2013 to February 2015. Patients were divided into A group and B group according to random number table. Among them, the treatment of group A was single celiac plexus block, and the treatment of group B was continuous diaphragm gap. The two groups of patients were treated at 1 month, 6 months, the excellent and good rates, and compared before treatment, treatment of 1 month and 6 months, the pain score, quality of life. Results The data showed that the excellent and good rates were similar between the two groups at one month of treatment. The pain scores and quality of life before treatment and one month after treatment were similar between the two groups. There was no significant difference between the two groups (P> 0.05). At 6 months, the excellent and good rates of patients in group B were significantly higher than those in group A, and the pain scores and quality of life were significantly better than those in group A, with significant difference (P <0.05). Conclusions The clinical effect of refractory upper abdominal cancer pain treated by continuous diaphragmatic posterior hindgut blockade is definite, which can reduce the pain and improve the quality of life of patients. It is worth popularizing.